bupropion has been researched along with B-Cell Lymphoma in 1 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
Excerpt | Relevance | Reference |
---|---|---|
" We report a patient who developed lymphocytoma cutis temporally associated with initiation of fluoxetine therapy that later went on to develop cutaneous marginal zone B-cell lymphoma." | 7.73 | Cutaneous marginal zone B-cell lymphoma in the setting of fluoxetine therapy: a hypothesis regarding pathogenesis based on in vitro suppression of T-cell-proliferative response. ( Breza, TS; Magro, CM; Porcu, P; Zheng, P, 2006) |
" We report a patient who developed lymphocytoma cutis temporally associated with initiation of fluoxetine therapy that later went on to develop cutaneous marginal zone B-cell lymphoma." | 3.73 | Cutaneous marginal zone B-cell lymphoma in the setting of fluoxetine therapy: a hypothesis regarding pathogenesis based on in vitro suppression of T-cell-proliferative response. ( Breza, TS; Magro, CM; Porcu, P; Zheng, P, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Breza, TS | 1 |
Zheng, P | 1 |
Porcu, P | 1 |
Magro, CM | 1 |
1 other study available for bupropion and B-Cell Lymphoma
Article | Year |
---|---|
Cutaneous marginal zone B-cell lymphoma in the setting of fluoxetine therapy: a hypothesis regarding pathogenesis based on in vitro suppression of T-cell-proliferative response.
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Bupropion; Cells, Cultured; Dose-Response | 2006 |